Warning: This profiles contains records that have been removed from public view per our opt-out policy.

Regeneron Pharmaceuticals Inc

Active Tarrytown, NY

(914)347-7000

Regeneron Pharmaceuticals Inc Overview

Regeneron Pharmaceuticals Inc filed as a Domestic Business Corporation in the State of New York on Monday, January 11, 1988 and is approximately thirty-six years old, as recorded in documents filed with New York Department of State.

Sponsored

Learn More D&B Reports Available for Regeneron Pharmaceuticals Inc

Network Visualizer

Name
Leonard S. Schleifer 1 ~ Background Report ~	President Chief Executive Officer Director NonDir NonPres CEO
Robert E. Landry 1 ~ Background Report ~	CFO NonTreas
George D. Yancopoulos ~ Background Report ~	Director Srvp NonDir President Vice President Executive Vice Presi
Marc Tessier-Lavigne ~ Background Report ~	Director NonDir
Christine A. Poon ~ Background Report ~	Director NonDir
George L. Sing ~ Background Report ~	Director NonDir
Arthur F. Ryan ~ Background Report ~	Director NonDir
Daniel P. Van Plew ~ Background Report ~	Evp Executive Srvp
Neil Stahl ~ Background Report ~	Evp Executive V.P.
Andrew Murphy ~ Background Report ~	Srvp
Pindaros R. Vagelos 1 ~ Background Report ~	NonDir Director
Charles A. Baker 1 ~ Background Report ~	NonDir Director
Joseph L. Larosa 1 ~ Background Report ~	NonSec Secretary Vice President
N. Anthony Coles ~ Background Report ~	NonDir Director
Bonnie L. Bassler ~ Background Report ~	NonDir Director
Michael S. Brown ~ Background Report ~	NonDir Director
Huda Y. Zoghbi ~ Background Report ~	NonDir
P. Roy Vagelos 1 ~ Background Report ~	Chairman Director
Leonard S. Schliefer 1 ~ Background Report ~	President CEO Chief Executive Officer Director Secretary
Larry J. Phillips ~ Background Report ~	President Director Secretary
S. Schleifer Ph D Leonard ~ Background Report ~	President
Murray A. Goldberg ~ Background Report ~	CFO Treasurer Director Secretary Vice President
Dominick Agron 1 ~ Background Report ~	Treasurer
Joseph W. Jensen ~ Background Report ~	Treasurer Director
Robert J. Terifay 1 ~ Background Report ~	Director
Alfred G. Gilman ~ Background Report ~	Director
Robert A. Ingram ~ Background Report ~	Director
Pindaros S. Vagelos ~ Background Report ~	Director
Peter Powchik ~ Background Report ~	Vice President
Phillip L. Young ~ Background Report ~	Vice President
Beth Levine ~ Background Report ~	Vice President

Showing 8 records out of 31

777 Old Saw Mill Rd Tarrytown, NY 10591 777 Old Saw Mill River Rd Tarrytown, NY 10591 100 Southgate Pkwy Morristown, NJ 07960 33 Riverside Ave Rensselaer, NY 12144 81 Columbia Tpke Rensselaer, NY 12144 777 Old Saw Ml Tarrytown, NY 10591

Florida Department of State

Filing Type:	Foreign for Profit Corporation
Status:	Active
State:	Florida
State ID:	F11000003622
Date Filed:	Wednesday, September 7, 2011

Texas Secretary of State

Filing Type:	Foreign For-Profit Corporation
Status:	Active In existence
State:	Texas
State ID:	801479947
Date Filed:	Tuesday, September 13, 2011

California Secretary of State

Filing Type:	Statement & Designation By Foreign Corporation
Status:	Active
State:	California
Foreign State:	New York
State ID:	03419675
Date Filed:	Friday, September 2, 2011

Nevada Secretary of State

Filing Type:	Foreign Corporation
Status:	Active
State:	Nevada
Foreign State:	New York
State ID:	E0551552011-8
Date Filed:	Wednesday, October 5, 2011
Registered Agent	The Corporation Trust Company of Nevada

New York Department of State

Filing Type:	Domestic Business Corporation
Status:	Active
State:	New York
Foreign State:	New York
County:	NEW YORK
State ID:	1226128
Date Filed:	Monday, January 11, 1988
DOS Process	C T Corporation System
Source Record	NY DOS

Corporate Notes

Date	Type	Note
1/11/1988	Name History/Actual	Regeneron Pharmaceuticals, Inc.
12/31/2010	Public Information Report (PIR)
9/13/2011	Application for Registration
10/5/2011	Foreign Qualification	Initial Stock Value: Par Value Shares: 200,000,000 Value: $ 0.001 Par Value Shares: 30,000,000 Value: $ 0.01 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 500,000.00
9/10/2012	Initial List
9/27/2012	Annual List
12/31/2012	Public Information Report (PIR)
12/31/2012	Public Information Report (PIR)
12/31/2012	Public Information Report (PIR)
9/10/2013	Annual List
12/2/2013	Change of Name or Address by Registered Agent
9/18/2014	Annual List
9/18/2015	Annual List
9/14/2016	Annual List
8/21/2017	Annual List
12/31/2017	Public Information Report (PIR)
8/27/2018	Annual List
12/31/2018	Public Information Report (PIR)
12/31/2020	Public Information Report (PIR)
12/31/2021	Public Information Report (PIR)
12/31/2023	Public Information Report (PIR)

Trademarks for Regeneron Pharmaceuticals Inc

	The Regeneron Science Competition Serial Number: 86920139 Drawing Code: 4000
	The Regeneron Prize Serial Number: 86920147 Drawing Code: 4000
	The Regeneron Prize for Creative Innovation Serial Number: 86920153 Drawing Code: 4000
	Regeneron Serial Number: 86910975 Drawing Code: 4000
	Serial Number: 86877289 Drawing Code:
	Velocimice Serial Number: 86644122 Drawing Code: 4000
	Velocimouse Serial Number: 86729551 Drawing Code: 3000
	Serial Number: 86729614 Drawing Code: 2000
	Regeneron Genetics Center Serial Number: 86644144 Drawing Code: 4000
	Regeneron Genetics Center Serial Number: 86644169 Drawing Code: 3000